Você já se inscreveu na nossa newsletter.
TPE in infusion therapy
Complex application techniques and a wide variety of different and specific application systems are used for infusing medication and nutritional components as well as for the transfusion of blood and blood components in order to administer therapeutic substances to patients both correctly and successfully.
Currently, there are four basic formulae available with varying property profiles in terms of mechanics and fluidity, on the basis of which other individual developments and application-oriented recipe modifications are possible.
However, multi-component technology also poses major challenges for the material. The substrate and overmolding can effectively complement each other. For this, the materials must be compatible. The materials to be selected depend on the function of the injection-molding parts and the respective manufacturing method. As the connection between the process and end product in multi-component injection molding is more complicated than for single-component injection molding, we recommend seeking expert advice when it comes to selecting materials. It is not, for example, only about the compatibility of plastics but also the particular requirements on adhesion. The material developments entail modifications of plastics enabling them to be optimized for the requirements of the actual products to be manufactured. For this reason, ACTEGA DS has adapted the TPE formulae to the special demands on optics, haptics, slip-resistance, secure grip and ergonomics. These SOFT EST. TPE are distinguished by their particular softness, easy coloration properties, good haptics, shorter cycle times in the injection-molding process, particularly good adhesion to PP and PE, and of course compliance with FDA und EU regulations. It is also possible to adapt these good adhesion properties to technical thermoplastics.
Find out for yourself about these and other applications at the ACTEGA DS stand at the K-Fair in Düsseldorf, October 16-23, 2019 in Hall 8A, Stand F 11-3.